![\"gulfo\"](\"http:\/\/blogs.shu.edu\/cancer\/files\/2014\/06\/gulfo.jpg\")
<\/p>\n<\/p>\n
Joseph V. Gulfo, MD, MBA, an alum and adjunct professor of Seton Hall University, manages the Cancer Biology blog.\u00a0He obtained a BS degree in Biology from Seton Hall University in 1984, and was the Valedictorian of the School of Arts & Sciences. He obtained an MD degree from Rutgers New Jersey Medical School (formerly the University of Medicine and Dentistry of NJ) in 1984 and an MBA from Seton Hall University in 1995.<\/p>\n
A serial entrepreneur, Dr. Gulfo is a leader in biopharma and medtech innovation and was responsible for the approval of a monoclonal antibody for prostate cancer (ProstaScint \u2013 Cytogen), a drug for bladder cancer (Valstar \u2013 Anthra Pharmaceuticals), and a medical device for melanoma detection (MelaFind \u2013 MELA Sciences).<\/p>\n
Dr. Gulfo is the author of two books \u2013 The Care Quotient: Transforming Business Through People<\/a><\/em> and \u00a0Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances<\/em><\/a>. He spearheads the Initiative for Patient-Centered Innovation<\/a> at Fairleigh Dickinson University and is a Visiting Scholar at the Mercatus Center<\/a> of George Mason University. A contributor to The Hill<\/a> and Inc.com<\/a>, Dr. Gulfo is also on the faculty of the GLG Institute Master Class program and a member of the Life Sciences Council of Springboard Enterprises<\/a>.<\/p>\n Twitter:\u00a0@josephgulfo<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":" Joseph V. Gulfo, MD, MBA, an alum and adjunct professor of Seton Hall University, manages the Cancer Biology blog.\u00a0He obtained a BS degree in Biology from Seton Hall University in 1984, and was the Valedictorian of the School of Arts & Sciences. He obtained an MD degree from Rutgers New Jersey Medical School (formerly the […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-6","page","type-page","status-publish","hentry"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/pages\/6","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/comments?post=6"}],"version-history":[{"count":5,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/pages\/6\/revisions"}],"predecessor-version":[{"id":3533,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/pages\/6\/revisions\/3533"}],"wp:attachment":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/media?parent=6"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nLinkedIn:\u00a0http:\/\/www.linkedin.com\/in\/josephgulfo<\/a><\/p>\n